Tuong Nguyen Ho

Dr. Tuong Nguyen Ho

Clinical Research Unit, Taipei Fertility Center, Taipei, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2023 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
CTChii-Ruey Tzeng
Chii-Ruey Tzeng
ZHZhongwei Huang
Zhongwei Huang
YAYoshimasa Asada
Yoshimasa Asada
CZCuilian Zhang
Cuilian Zhang
MHManh Tuong Ho
Manh Tuong Ho
THTuong Nguyen Ho
Tuong Nguyen Ho
How do age, ethnicity, and other characteristics affect serum anti-mullerian hormone (AMH) levels in Asian women undergoing fertility treatment? Age, ethnicity, obesity (BMI ≥ 30 kg/m2), and polycystic ovarian syndrome (PCOS) significantly impacted serum AMH levels, with the rate of decrease accelerating as age increased; a concentration of 4.0 ng/ml was the optimal cut-off for diagnosis of PCOS. There are significant differences in ovarian reserve among women from different races and ethnicities, and Asian women often have poorer reproductive outcomes during assisted reproductive treatment cycles. A population-based multi-nation, multi-centre, multi-ethnicity prospective cohort study of 4613 women was conducted from January 2020 to May 2021. Infertile women of 20–43 years of age were enrolled. The exclusion criteria included: age 43, non-Asian ethnicity, and missing critical data. Participants were Asian women of Chinese, Japanese, Korean, Thai, Vietnamese, Malay, Indian, and Indonesian ethnicities from 12 IVF centres across Asia. These women were all naïve to ovarian stimulation cycles and attended IVF centres for fertility assessment. The AMH measurement was performed using an AMH automated assay on a clinically validated platform. A total of 4556 infertile Asian women were included in the final analyses. The mean ± SD for serum AMH concentrations (ng/ml) across specific age groups were: overall, 3.44 ± 2.93; age <30, 4.58 ± 3.16; 30–31, 4.23 ± 3.23; 32–33, 3.90 ± 3.06; 34–35, 3.21 ± 2.65; 36–37, 2.74 ± 2.44; 38–39, 2.30 ± 1.91; 40 and above, 1.67 ± 2.00. The rate of AMH decrease was ∼0.13 ng/ml/year in patients aged 25–33 and 0.31 ng/ml/year in women aged 33–43. The highest rates of PCOS were found in Indians (18.6%), Malays (18.9%), and Vietnamese (17.7%). Age (P < 0.001), ethnicity (P < 0.001), obesity (P = 0.007), PCOS (P < 0.001), and a history of endometrioma cystectomy (P = 0.01) were significantly associated with serum AMH values. Smoking status, pretreatment with GnRH agonist (GnRHa) or the oral contraceptive pill (OCP), freezing-thawing of blood samples, and sampling on Day 2 to Day 5 of the menstrual cycle or randomly did not appear to affect serum AMH levels. An AMH concentration of 4.0 ng/ml was the optimal cut-off for PCOS diagnosis with a sensitivity of 71.7% and specificity of 75.8% (AUC = 0.81, CI 95%: 0.79–0.83; P < 0.001). The incidence of PCOS was supposedly high in this cohort as some IVF clinics were tertiary referral centres for managing specific fertility issues encountered by women with PCOS. Treatment with GnRHa or OCP before AMH testing was regionally and ethnically confined, mostly in Hong Kong SAR and Japan. Moreover, this reference for serum AMH value is limited to Asian women of the ethnicities examined and may not apply to other ethnicities not included in the study. This is the first study to collate and construct age-specific reference ranges for serum AMH levels using the same bioassay on Asian women of different ethnicities. The findings of this investigation can assist clinicians to counsel and prognosticate about Asian women’s ovarian reserve and reproductive potential, thus providing better strategies for personalized fertility interventions. This study was technically supported by Ferring Pharmaceuticals and received no specific grant from any funding agency. All authors have no competing interests to disclose. NCT04203355.

Verified
Journal Article
Open access
PDF file
THTuong Nguyen Ho
Tuong Nguyen Ho
SLShu-Wei Lin
Shu-Wei Lin
YLYi-Rong Lee
Yi-Rong Lee
CTChii-Ruey Tzeng
Chii-Ruey Tzeng
SKShu-Huei Kao
Shu-Huei Kao
Osteopontin (OPN) isoforms, including OPNb and OPNc, promote malignancy and may contribute to the pathogenesis of endometriosis, a benign disorder with multiple characteristics resembling malignant tumors. In our experiments, OPNb and OPNc were significantly overexpressed in both endometriosis and adenomyosis compared to the normal endometrium. Upregulation of CD44v and the epithelial–mesenchymal transition (EMT) process was also present in endometriotic lesions. Overexpression of OPNb and OPNc splicing variants in endometriotic cells evoked morphological changes, actin remodeling, cell proliferation, cell migration, and EMT through binding OPN ligand receptors CD44 and αvβ3, subsequently activating the PI3K and NF-ĸB pathways. We elucidated the causal role of OPN splice variants in regulating endometriotic cell growth, which may promote the development of OPN-targeted therapies for patients suffering from endometriotic disorders.

4 July 2024 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
TLThi-My-Trang Luong
Thi-My-Trang Luong
THTuong Nguyen Ho
Tuong Nguyen Ho
YHYuh-Ming Hwu
Yuh-Ming Hwu
SLShyr-Yeu Lin
Shyr-Yeu Lin
JHJason Yen-Ping Ho
Jason Yen-Ping Ho
CTChii-Ruey Tzeng
Chii-Ruey Tzeng

12 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DNDoan Phuong Quy Nguyen
Doan Phuong Quy Nguyen
SPSon Pham
Son Pham
AJAmadou Wurry Jallow
Amadou Wurry Jallow
THTuong Nguyen Ho
Tuong Nguyen Ho
BLBao Le
Bao Le
YLYung-Feng Lin
Yung-Feng Lin
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder afflicting the elderly population worldwide. The identification of potential gene candidates for AD holds promises for diagnostic biomarkers and therapeutic targets. Employing a comprehensive strategy, this study integrated transcriptomic data from diverse data sources, including microarray and single-cell datasets from blood and tissue samples, enabling a detailed exploration of gene expression dynamics. Through this thorough investigation, 19 notable candidate genes were found with consistent expression changes across both blood and tissue datasets, suggesting their potential as biomarkers for AD. In addition, single cell sequencing analysis further highlighted their specific expression in excitatory and inhibitory neurons, the primary functional units in the brain, underscoring their relevance to AD pathology. Moreover, the functional enrichment analysis revealed that three of the candidate genes were downregulated in synaptic signaling pathway. Further validation experiments significantly showed reduced levels of rabphilin-3A (RPH3A) in 3xTg-AD model mice, implying its role in disease pathogenesis. Given its role in neurotransmitter exocytosis and synaptic function, further investigation into RPH3A and its interactions with neurotrophic proteins may provide valuable insights into the complex molecular mechanisms underlying synaptic dysfunction in AD.

29 November 2023 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
HTHuy Phuong Tran
Huy Phuong Tran
NNNam Nhat Nguyen
Nam Nhat Nguyen
THTuong Nguyen Ho
Tuong Nguyen Ho
TTThuy Thi-Thanh Tran
Thuy Thi-Thanh Tran
LLLoc Thai Ly
Loc Thai Ly
LTLe-Giang Tran
Le-Giang Tran

29 March 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
THTuong Nguyen Ho
Tuong Nguyen Ho
DHDang Khanh Ngan Ho
Dang Khanh Ngan Ho
XTXuan-Hong Tomai
Xuan-Hong Tomai
NNNam Nhat Nguyen
Nam Nhat Nguyen
HNHung Song Nguyen
Hung Song Nguyen
CTChii-Ruey Tzeng
Chii-Ruey Tzeng
This study investigates the effect of GnRHa pretreatment on pregnancy outcomes in artificial endometrial preparation for frozen–thawed embryo transfer (AC-FET) cycles. A systematic review of English language studies published before 1 September 2022, was conducted, excluding conference papers and preprints. Forty-one studies involving 43,021 participants were analyzed using meta-analysis, with a sensitivity analysis ensuring result robustness. The study found that GnRHa pretreatment generally improved the clinical pregnancy rate (CPR), implantation rate (IR), and live birth rate (LBR). However, discrepancies existed between randomized controlled trials (RCTs) and observational studies; RCTs showed no significant differences in outcomes for GnRHa-treated cycles. Depot GnRHa protocols outperformed daily regimens in LBR. Extended GnRHa pretreatment (two to five cycles) significantly improved CPR and IR compared to shorter treatment. Women with polycystic ovary syndrome (PCOS) saw substantial benefits from GnRHa pretreatment, including improved CPR and LBR and reduced miscarriage rates. In contrast, no significant benefits were observed in women with regular menstruation. More rigorous research is needed to solidify these findings.